[
  {
    "ref_criterion": "Accurately outlines the complete pneumococcal vaccination sequence for immunocompromised adults, including both initial vaccine selection and booster timing.",
    "ref_axis": "accuracy",
    "ref_point": 10,
    "gen_criterion": "Provides a detailed explanation of the pneumococcal vaccine booster for high-risk patients.",
    "gen_axis": "completeness",
    "gen_point": 8,
    "similarity": 0.7852,
    "point_diff": 2,
    "score": 0.785,
    "similar_match": true,
    "axis_match": false
  },
  {
    "ref_criterion": "Correctly identifies the current CDC-recommended pneumococcal vaccine options for immunocompromised adults: PCV15 followed by PPSV23, PCV20 alone, or PCV21 alone.",
    "ref_axis": "accuracy",
    "ref_point": 8,
    "gen_criterion": "Provides a detailed explanation of the pneumococcal vaccine booster for high-risk patients.",
    "gen_axis": "completeness",
    "gen_point": 8,
    "similarity": 0.6314,
    "point_diff": 0,
    "score": 0.631,
    "similar_match": true,
    "axis_match": false
  },
  {
    "ref_criterion": "Specifies the correct timing between PCV15 and PPSV23 in immunocompromised adults (minimum interval of 8 weeks) versus the general adult population (1-year interval).",
    "ref_axis": "accuracy",
    "ref_point": 7,
    "gen_criterion": "Mentions the importance of referencing the CDC\u2019s adult immunocompromised schedule for accurate guidance.",
    "gen_axis": "context_awareness",
    "gen_point": 6,
    "similarity": 0.5551,
    "point_diff": 1,
    "score": 0.555,
    "similar_match": true,
    "axis_match": false
  },
  {
    "ref_criterion": "Correctly addresses the need for additional PPSV23 boosters for immunocompromised adults five years after the initial PPSV23 dose when applicable to their vaccination history.",
    "ref_axis": "accuracy",
    "ref_point": 7,
    "gen_criterion": "Provides a clear and concise explanation of the booster timelines for immunosuppressed adults.",
    "gen_axis": "communication_quality",
    "gen_point": 9,
    "similarity": 0.5825,
    "point_diff": 2,
    "score": 0.583,
    "similar_match": true,
    "axis_match": false
  },
  {
    "ref_criterion": "Provides clear guidance on completing the pneumococcal vaccination series for immunocompromised adults with incomplete or partial vaccination histories.",
    "ref_axis": "completeness",
    "ref_point": 6,
    "gen_criterion": "Provides a detailed explanation of the pneumococcal vaccine booster for high-risk patients.",
    "gen_axis": "completeness",
    "gen_point": 8,
    "similarity": 0.7201,
    "point_diff": 2,
    "score": 0.72,
    "similar_match": true,
    "axis_match": true
  },
  {
    "ref_criterion": "Discusses considerations for timing pneumococcal vaccination in relation to immunosuppressive therapies or treatments.",
    "ref_axis": "context_awareness",
    "ref_point": 5,
    "gen_criterion": "Provides a detailed explanation of the pneumococcal vaccine booster for high-risk patients.",
    "gen_axis": "completeness",
    "gen_point": 8,
    "similarity": 0.7499,
    "point_diff": 3,
    "score": 0.75,
    "similar_match": true,
    "axis_match": false
  },
  {
    "ref_criterion": "Includes appropriate clinical terminology such as \"PCV\" (pneumococcal conjugate vaccine), \"PPSV23\" (pneumococcal polysaccharide vaccine), and serotype coverage when discussing vaccine options.",
    "ref_axis": "communication_quality",
    "ref_point": 4,
    "gen_criterion": "Provides a detailed explanation of the pneumococcal vaccine booster for high-risk patients.",
    "gen_axis": "completeness",
    "gen_point": 8,
    "similarity": 0.6299,
    "point_diff": 4,
    "score": 0.504,
    "similar_match": true,
    "axis_match": false
  },
  {
    "ref_criterion": "References the updated CDC guidance lowering the age for routine pneumococcal vaccination from 65 to 50 years (as of 2025).",
    "ref_axis": "accuracy",
    "ref_point": 3,
    "gen_criterion": "Provides a detailed explanation of the pneumococcal vaccine booster for high-risk patients.",
    "gen_axis": "completeness",
    "gen_point": 8,
    "similarity": 0.6445,
    "point_diff": 5,
    "score": 0.516,
    "similar_match": true,
    "axis_match": false
  },
  {
    "ref_criterion": "Fails to mention the need for additional PPSV23 boosters (beyond the initial PCV15\u2192PPSV23 sequence) for immunocompromised adults.",
    "ref_axis": "completeness",
    "ref_point": -9,
    "gen_criterion": "Provides a clear and concise explanation of the booster timelines for immunosuppressed adults.",
    "gen_axis": "communication_quality",
    "gen_point": 9,
    "similarity": 0.56,
    "point_diff": 18,
    "score": 0.0,
    "similar_match": true,
    "axis_match": false
  },
  {
    "ref_criterion": "Incorrectly states that PCV15, PCV20, and PCV21 all require PPSV23 follow-up in immunocompromised adults. (Justification: PCV20 and PCV21 are standalone vaccines that do not require PPSV23 follow-up, while PCV15 does require it.)",
    "ref_axis": "accuracy",
    "ref_point": -8,
    "gen_criterion": "Incorrectly states that the HPV vaccine is only recommended for adults up to age 45.",
    "gen_axis": "accuracy",
    "gen_point": -6,
    "similarity": 0.5359,
    "point_diff": 2,
    "score": 0.536,
    "similar_match": true,
    "axis_match": true
  },
  {
    "ref_criterion": "Provides outdated pneumococcal vaccination guidance (prior to 2024-2025 updates) without noting that the information may not reflect current recommendations.",
    "ref_axis": "accuracy",
    "ref_point": -7,
    "gen_criterion": "Fails to mention the pneumococcal vaccine booster for high-risk patients.",
    "gen_axis": "completeness",
    "gen_point": -8,
    "similarity": 0.6789,
    "point_diff": 1,
    "score": 0.679,
    "similar_match": true,
    "axis_match": false
  },
  {
    "ref_criterion": "Fails to differentiate between vaccination schedules for immunocompetent versus immunocompromised adults.",
    "ref_axis": "accuracy",
    "ref_point": -6,
    "gen_criterion": "Provides a general overview of the recommended vaccination schedule for immunosuppressed adults.",
    "gen_axis": "completeness",
    "gen_point": 8,
    "similarity": 0.7788,
    "point_diff": 14,
    "score": 0.0,
    "similar_match": true,
    "axis_match": false
  },
  {
    "ref_criterion": "Provides vague booster timing recommendations without specific intervals (e.g., \"get a booster later\" instead of \"5 years after initial PPSV23 dose\").",
    "ref_axis": "accuracy",
    "ref_point": -5,
    "gen_criterion": "Mentions the importance of consulting local guidelines or clinical judgment for specific booster timelines.",
    "gen_axis": "completeness",
    "gen_point": 5,
    "similarity": 0.6266,
    "point_diff": 10,
    "score": 0.0,
    "similar_match": true,
    "axis_match": false
  },
  {
    "ref_criterion": "Includes unnecessary technical details about vaccine composition, manufacturing processes, or historical development that distract from practical clinical guidance.",
    "ref_axis": "communication_quality",
    "ref_point": -4,
    "gen_criterion": "Mentions the importance of referencing the CDC\u2019s adult immunocompromised schedule for accurate guidance.",
    "gen_axis": "context_awareness",
    "gen_point": 6,
    "similarity": 0.5691,
    "point_diff": 10,
    "score": 0.0,
    "similar_match": true,
    "axis_match": false
  }
]